Articles from Biosero, Inc.

BD (Becton, Dickinson and Company) (NYSEBDX), a leading global medical technology company, and Biosero, a developer of laboratory automation solutions to orchestrate scientific discoveries, today announced a framework collaboration agreement to enable and facilitate robotic arm integration with BD flow cytometry instruments to accelerate drug discovery and development.

Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, and BioNex Solutions, Inc., provider of advanced laboratory automation systems, today announced a collaboration designed to deliver an enhanced experience for customers using the Hive Laboratory Automation platform.

Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, today announced the appointment of Daniel Schumann to the position of chief operations officer. Starting in April, Mr. Schumann will be responsible for overseeing all operational functions, including supply chain, procurement, integrations, engineering, project management, quality, and IT.

Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, today announced the promotion of Ryan Bernhardt to the position of Chief Executive Officer. Mr. Bernhardt previously served as the company’s Chief Commercial Officer. Tom Gilman, Biosero’s founding CEO and president, will work closely with Mr. Bernhardt through September 30, 2023 to transition responsibilities.

Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, today announced the promotion of Rob Harkness, PhD, to the position of Chief Technology Officer. Dr. Harkness previously served as the company’s managing director for the European Union and United Kingdom.

Hamilton and Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, today announced a strategic co-marketing agreement aimed at streamlining automated liquid handling workflows. The partnership builds on Hamilton’s state-of-the-art automated platforms and Biosero’s innovative Green Button Go® Software Suite to increase lab efficiency.

Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, and Analytik Jena today announced a co-marketing agreement that will allow the companies to promote applications of their combined laboratory automation technologies that will enable customers to accelerate and optimize their scientific research. Biosero and Analytik Jena will be demonstrating these workflows at the SLAS2023 International Conference and Exhibition taking place in San Diego from February 25 to March 1.

Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, and AltemisLab, leaders of sample management consumables and equipment to optimize inventory management workflows, today announced a collaboration that will streamline sample management automation for customers. The companies will also be showcasing their joint technology approach at the SLAS2023 International Conference and Exhibition taking place in San Diego from February 25 to March 1.

Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, and Virscidian, developer of solutions to automate LC/MS (liquid chromatography and mass spectrometry) decision-driven workflows, today announced a collaboration and co-marketing agreement through which the companies will support fully automated analytical workflows for medicinal chemistry as well as other scientific applications, including accelerated screening for drug metabolism and pharmacokinetics (DMPK).

Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, and DeepCure, a therapeutics company powered by next-generation AI and AI-enabling technologies, today announced their collaboration on an advanced, fully automated chemistry synthesis platform to accelerate drug discovery. The platform, which is part of DeepCure’s Molecular Foundry, based in Rehovot, Israel, will be powered by DeepCure’s innovative AI engine and Biosero’s Green Button Go® suite of laboratory automation software.

Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, announced that its Acceleration Lab has been named a winner of the 2022 Sales and Marketing Technology Awards from the Business Intelligence Group. The awards, known as “The Sammys,” honor organizations and products helping to solve the challenges organizations have connecting and collaborating with prospects and customers.

Biosero, Inc., a BICO company and developer of laboratory automation solutions to orchestrate scientific discoveries, announced the issuance of a key patent underlying its Green Button Go® Scheduler, laboratory automation scheduling software. This patent will accelerate the Bioconvergence Revolution by enabling the implementation of larger, more connected automated scientific solutions while also providing an unprecedented degree of process flexibility that has been missing in lab automation to date.

Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, today announced that it has joined the Genedata Ready-to-Run program, which helps to accelerate drug discovery with frictionless integrations that streamline laboratory automation processes in biopharmaceutical companies. Through this agreement, customers of both companies will experience more seamless connections between Biosero’s Green Button Go® lab automation software and Genedata Screener®, a platform for bioassay data analysis and management used by the majority of the top 50 biopharma companies worldwide.

Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, today announced a collaboration with Araceli Biosciences that will allow scientists to integrate Araceli’s Endeavor™ high-speed imaging platform into automated workflows controlled by Biosero’s Green Button Go® software suite.

Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, today announced that its Chief Technology Officer David Dambman has been honored by the 2021 Top Tech Awards, recognizing his leadership and ability to solve technical challenges.

Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, and Bio-Strategy, a leading Australian distributor of equipment and consumables, today announced a distribution agreement to bring Biosero’s Green Button Go® lab automation software and integration solutions to scientists in Australia, New Zealand, and the South Pacific (collectively known as ANZ). The collaboration will give ANZ research institutions and organizations access to cutting-edge automation features to improve performance across life science laboratories.

Biosero, Inc., developer of automation solutions that enable laboratories to make better decisions in less time using more data, today announced that its founder and CEO Tom Gilman has been named a CEO of the Year by the San Diego Business Journal. The award honors chief executives of companies located in San Diego County for achievements within their companies and in the community.

Biosero, Inc., developer of automation solutions that enable laboratories to make better decisions in less time using more data, today announced two key hires as it expands commercial operations. Ryan Bernhardt joins the company as Chief Commercial Officer, and Ruth Petersen is named Director of Marketing.